Nektar Therapeutics' experimental eczema drug meets main goals of mid-stage trial-February 2024-www.financetom.com

Business

Nektar Therapeutics' experimental eczema drug meets main goals of mid-stage trial

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Nektar Therapeutics' experimental eczema drug meets main goals of mid-stage trial

Jun 24, 2025 5:16 AM

June 24 (Reuters) - Nektar Therapeutics ( NKTR ) said on

Tuesday its experimental eczema drug had met the main goals of a

mid-stage study.

Shares of the company were halted in premarket trading.

Previous page： Palantir Technologies Insider Sold Shares Worth $369,908,300, According to a Recent SEC Filing Next page： Roblox Insider Sold Shares Worth $1,279,670, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Palantir Technologies Insider Sold Shares Worth $369,908,300, According to a Recent SEC Filing

Dec 4, 2024

03:26 AM EST, 12/04/2024 (MT Newswires) -- Shyam Sankar, Chief Technology Officer and Executive Vice President, on November 29, 2024, sold 5,280,000 shares in Palantir Technologies ( PLTR ) for $369,908,300. Following the Form 4 filing with the SEC, Sankar has control over a total of 1,502,685 shares of the company, with 752,786 shares held directly and 749,899 controlled indirectly....

Roblox Insider Sold Shares Worth $1,279,670, According to a Recent SEC Filing

Dec 4, 2024

03:27 AM EST, 12/04/2024 (MT Newswires) -- Anthony P Lee, Director, on December 02, 2024, sold 25,000 shares in Roblox ( RBLX ) for $1,279,670. Following the Form 4 filing with the SEC, Lee has control over a total of 26,929,608 shares of the company, with 26,929,608 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1315098/000141588924028201/xslF345X05/form4-12042024_121223.xml ...

Arlo Technologies Insider Sold Shares Worth $3,653,818, According to a Recent SEC Filing

Dec 4, 2024

03:21 AM EST, 12/04/2024 (MT Newswires) -- Matthew Blake McRae, Director, Chief Executive Officer, on December 02, 2024, sold 316,644 shares in Arlo Technologies ( ARLO ) for $3,653,818. Following the Form 4 filing with the SEC, McRae has control over a total of 3,160,988 shares of the company, with 3,160,988 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1736946/000141588924028207/xslF345X05/form4-12042024_011218.xml ...

Netflix Insider Sold Shares Worth $43,362,185, According to a Recent SEC Filing

Dec 4, 2024

03:23 AM EST, 12/04/2024 (MT Newswires) -- Reed Hastings, Director, Executive Chairman, on December 02, 2024, sold 48,363 shares in Netflix ( NFLX ) for $43,362,185. Following the Form 4 filing with the SEC, Hastings has control over a total of 2,154,355 shares of the company, with 114 shares held directly and 2,154,241 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1065280/000106528024000345/xslF345X05/wk-form4_1733274802.xml ...

About

Terms and Conditions Privacy policy Cookie Settings Contact Us

Services

financetom Market Personal Finance Business Economy Cryptocurrency MAP